Blackstone Secures $12.6M in Financing, Plans to Sharpen Life Science Focus | GenomeWeb

NEW YORK, June 4 – Blackstone Technology Group, a provider of high-throughput computing software and services based in Worcester, Mass., said Monday it has closed a $12.6 million Series B round of venture financing led by Ampersand Ventures. 

Co-investors in the funding included Softbank Investment Corp., Garfly Invest AG, Itochu International, and Synopsys. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.